Clinical Trial Update: A Clinical Evaluation of the Aliya™ System in Late Stage Cancer [NA]

View source ↗

Summary

A clinical trial evaluating the Aliya System in late-stage cancer has been terminated. The study included patients with lung, kidney, or liver cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer
• Liver Cancer
• Lung Cancer

Snippet

Sponsor: Galvanize Therapeutics, Inc. | Conditions: Cancer of Lung, Kidney or Liver | NA | Status: TERMINATED